Document:

EX-10.13

 Exhibit 10.13 
 SENIOR EXECUTIVE OFFICER SEVERANCE AGREEMENT 
 THIS SENIOR EXECUTIVE OFFICER SEVERANCE
AGREEMENT is made as of July 30, 2012, between TELEFLEX MEDICAL EUROPE LTD. with a registered address of Garrycastle Business & Technology Park, Athlone, Co. Westmeath, Ireland (the “Company”) and LIAM KELLY of
[ADDRESS INTENTIONALLY DELETED] (“Executive”). 
 Background 

 

	A.	Executive is employed by the Company as the Company’s EVP and President International. 

 

	B.	The purpose of this Agreement is to provide for certain severance compensation and benefits to be paid or provided to Executive in the event of the termination of his
employment under circumstances specified herein and to provide also for certain commitments by Executive respecting the Company and Group. 

 Terms 
 THE PARTIES, in consideration of the mutual covenants hereinafter set forth, and
intending to be legally bound hereby, agree as follows: 
  

	1.	Definitions 

 The following terms used in
this Agreement with initial capital letters have the respective meanings specified therefor in this Section. 
 “Affiliate” of any
Person means any other Person that controls, is controlled by or is under common control with the first mentioned Person. 

“Agreement” preceded by the word “this” means this Senior Executive Officer Severance Agreement, as amended at any relevant time.

 “Annual Incentive Plan” means the Management Incentive Plan (MIP) or Executive Incentive Plan (EIP) which are offered by the
Company providing for the payment of annual bonuses to certain employees of the Company, including Executive, as such Plans may be amended from time to time or, if such Plans shall be discontinued, any similar Plan or Plans in effect at any relevant
time. 
 “Base Salary” of Executive means the annualized base rate of salary paid to Executive as such may be increased from time to
time. 
 “Board” means the Board of Directors of the Company. 

 “Cause” means (a) misappropriation of funds, (b) conviction of a crime involving moral
turpitude, (c) gross negligence in the performance of duties, which gross negligence has had a material adverse effect on the business, operations, assets, properties or financial condition of the Company and its subsidiaries taken as a whole
or (d) refusal to comply with clause 2 of the Contract of Employment. 
 “Change In Control Severance Agreement” means any
Executive Severance Agreement relating to termination of employment of Executive after the occurrence of a Change if Control of the Company (defined in such Agreement). 
 “Confidential Information” has the meaning specified in Section 7. 
 “Contract
of Employment” shall mean the contract of employment entered into between the Company and Executive of July 30, 2012. 

“Employment” means substantially full time employment of Executive by the Company or any of its Affiliates. 

“Group” means the Company and all Affiliates. 
 “Health Care Continuation Period” means the period commencing on the Termination Date and ending on the earlier of (i) the last day of the Severance Compensation Period or (ii) the
first date on which Executive is eligible to participate in a health care plan maintained by another employer. 
 “Insurance Benefits
Period” means the period commencing on the Termination Date and ending on the earlier of (i) the last day of the Severance Compensation Period or (ii) the first date on which Executive is eligible to participate in a life and / or
accident insurance plan maintained by another employer. 
 “Notice of Termination” shall mean notice of termination under the Contract
of Employment. 
 “Performance Period” applicable to any compensation payable (in cash or other property) under any Plan, the amount
or value of which is determined by reference to the performance of participants or the Company or the fulfillment of specified conditions or goals, means the period of time over which such performance is measured or the period of time in which such
conditions or performance goals must be fulfilled. 
 “Person” means an individual, a corporation or other entity or a government or
governmental agency or institution, which may include a Restricted Competitor. 
 “Plan” means a plan of the Company or Group for the
payment of compensation or provision of benefits to employees in which plan Executive is or was, at all times relevant to the provisions of this Agreement, a participant or eligible to participate. 

“Prorated Amount” has the meaning specified in Section 3(c). 

  
 2 

 “Release” has the meaning specified in Section 6. 

“Relevant Business” means the business or businesses from time to time carried on by the Group limited to the activities with which the
Executive was materially concerned or involved in the course of his employment during the 12 month period prior to the Termination Date; 

“Restricted Area” means the international territory in which you managed the Company’s business in the twelve months prior to the
Termination Date; 
 “Restricted Competitor” means CR Bard, Covidian, Coloplast, Astra Tech (div. of Dentsply), Smiths Medical,
Intersurgical, B. Braun, Vygon, Pajunk, Ambu, and / or CareFusion, or any merged, acquiring or successor entity of any one of these organisations, or any third party that may, between the commencement of this Agreement and the Termination Date,
acquire all or a substantial part of the assets or business of any one of these organisations. 
 “Severance Compensation Period”
means the 15 month period commencing on the day after the Termination Date. 
 “Termination Date” means the date specified in a Notice
of Termination, as may be amended by the Company, which date shall be the date Executive’s Termination of Employment occurs. 

“Termination of Employment” means a cessation of Employment for any reason, other than a cessation occurring (i) by reason of
Executive’s death or (ii) under circumstances which would entitle Executive to receive compensation and benefits pursuant to the Executive Change In Control Severance Agreement, or (iii) for Cause. 

“Year” means a fiscal year of the Company. 
  

	2.	Continued Employment of Executive 

The parties acknowledge that Executive’s employment by the Company is terminable on notice and subject to such terms and conditions
as contained in the Contract of Employment. Nothing in this Agreement shall be construed as giving Executive any right to continue in the employ of the Company. 

  
 3 

	3.	Compensation upon Termination of Employment. 

 Subject to the strict compliance with the terms of this Agreement, upon Termination of Employment by the Company other than for Cause, Executive will receive from the Company the following payments and
benefits, which shall be inclusive of any statutory redundancy payment which Executive is entitled to receive: 
  

	(a)	Cash Bonuses for Years Preceding the Year of Termination. 

 If any cash bonus pursuant to an Annual Incentive Plan in respect of a Performance Period which ended before the Year of Termination shall not have been paid to Executive on or before the Termination
Date, the Company will pay Executive such bonus in the amount of Executive’s award earned for the Performance Period in the form of a single lump sum cash payment on the later of the 15th day following the Termination Date or the date that is
2-1/2 months following the end of the Performance Period. Save as provided for in clause 3(c), no other bonus payment shall be payable. 
  

	(b)	Continuation of Base Salary 

 The
Company will pay Executive an amount equivalent to 15 months of Executive’s Base Salary as in effect immediately prior to the Termination Date, payable in accordance with the Company’s normal payroll schedule and payroll practices in
effect from time to time, subject to all applicable withholdings and deductions. Provided, however, that if the Termination Date was preceded by a period of illness leave, then the Base Salary continuation shall be an amount equivalent to 15 months
of Executive’s Base Salary as in effect immediately prior to the Executive’s illness leave. 
 In the event that
Executive is made redundant, then any statutory redundancy payment to which Executive is entitled shall be calculated as of the Termination Date. The amount of the statutory redundancy payment shall be subtracted from Executive’s base salary
continuation and paid out in a lump sum following the expiration of a waiting period of that period of time which it would otherwise have taken Executive to receive the equivalent of the statutory redundancy payment under the Company’s normal
payroll schedule and payroll practices in effect as of the Termination Date. 
  

	(c)	Payment of Annual Incentive Plan Award for Performance Period Not Completed Before the Termination Date 

If the Termination Date occurs before the last day, but after completion of at least six months, of a Performance Period under the Annual
Incentive Plan, the Company will pay Executive the Prorated Amount of Executive’s award under the Annual Incentive Plan for that Performance Period. The amount of the award, from which the Prorated Amount is derived, shall be determined based
on the degree to which each performance goal on which such award is based has been achieved at the end of the Performance Period (provided that any individual performance component shall be equal to the target award amount for such component). The
“Prorated Amount” of the award means an amount equal to the portion of the award which bears the same ratio to the amount of the award as the portion of such Performance Period expired immediately before the Termination Date bears to the
entire period of such Performance Period. The amount to which Executive is entitled under this Section 3(c) shall be paid in the form of a single lump sum cash payment on the date that is 2-1/2 months following the end of the Performance
Period. 

  
 4 

	(d)	Vehicle Allowance 

 Subject to
statutory deductions, during the Severance Compensation Period, the Company shall continue to pay Executive his monthly cash vehicle allowance that was in effect as of the Termination Date, in accordance with the Company’s normal payment
schedule and payment practices in effect from time to time. 
  

	(e)	Outplacement 

 The Company shall
reimburse Executive for expenses incurred for outplacement services during the Severance Compensation Period, up to a gross maximum aggregate amount of €16,000 inclusive of VAT and outlay, which services shall be provided by an outplacement
agency selected by Executive. The Company shall reimburse Executive within 15 days following the date on which the Company receives proof of payment of such expense, which proof must be submitted no later than December 1st of the calendar year
after the calendar year in which the expense was incurred and although addressed to Executive the amount will be payable by the Company. Notwithstanding the foregoing, Executive shall only be entitled to reimbursement for those outplacement service
costs incurred by Executive on or prior to the last day of the second year following the Termination Date. Any such payment may be subject to statutory deductions. 
  

	(f)	Health Care Coverage 

 Subject to
statutory deductions, during the Health Care Continuation Period, the Company will provide health care coverage under the Company’s then-current health care Plan for Executive and Executive’s spouse and eligible dependents on the same
basis as if Executive had continued to be employed during that period. If not permitted under the relevant Plan, and subject to statutory deductions, the Company shall pay an amount equivalent to the cost to it of providing cover for the Executive
and Executive’s spouse and eligible dependants on the same basis as if the Executive had continued to be a member of the Plan during the Health Care Continuation Period. 

 

	(g)	Life and Accident Insurance 

Subject to statutory deductions and the terms, limitations and exclusions of the Plan or Plans for provision of life and accident
insurance and the Company’s related policies of group insurance, during the Insurance Benefits Period the Company will provide life and accident insurance coverage for Executive comparable to the life and accident insurance coverage which
Executive last elected to receive as an employee under the applicable Plan for such benefits, subject to modifications from time to time of the coverage available under such Plan or related insurance policies which are applicable generally to global
executive officers. The cost of providing such insurance will be borne by the Company and Executive in accordance with the Company’s policy then in effect for employee participation in premiums, on substantially the same terms as would be
applicable to a global executive officer. The Company shall pay its share of such premiums to the applicable insurance carrier(s) on the due date(s) established by such 

  
 5 

 
carrier(s), but in no event later than the last day of the calendar year in which such due date(s) occurs. If not permitted under the relevant Plan, and subject to statutory deductions, the
Company shall pay an amount equivalent to the cost to it of providing cover for the Executive and Executive’s spouse and eligible dependants on the same basis as if the Executive had continued to be a member of the Plan during the Health Care
Continuation Period. 
  

	(h)	Taxable Benefits 

 The Company
shall deduct all taxes and levies from any emoluments, payments or benefits provided under this Agreement (including PAYE, employees PRSI, health contributions or any other taxes or levies which the Company and/or Group is obliged to deduct from
emoluments, payments or benefits provided to Executive, but excluding employers PRSI). In the event that the amounts deducted are insufficient to discharge the Company’s liability, Executive hereby agrees to indemnify the Company and / or Group
for all taxes and benefit contributions arising therefrom. The Company shall pay all interest, penalties, costs, and expenses incurred due to its own negligent failure to make required deductions from Executive’s compensation. The amount
payable by Executive under this clause will be such amount as will leave the Executive in the same position (after settling all taxes, levies, interest, penalties, costs and expenses), as he would have been if the correct deductions had been made
from all emoluments, payments or benefits provided under this Agreement at the time such deductions were due. 
  

	4.	Deductions and Taxes 

 For the
avoidance of doubt, all amounts payable or benefits provided by the Company pursuant to this Agreement shall be paid net of (i) taxes withheld or deducted by the Company in accordance with the requirements of law and (ii) deductions for
the portion of the cost of certain benefits to be borne by Executive. The Company reserves absolute discretion to determine the manner in which tax should be applied to any such amounts or benefits. 

 

	5.	Compensation and Benefits Pursuant to Other Agreements and Plans 

 Nothing in this Agreement is intended to diminish or otherwise affect Executive’s right to receive from the Company all compensation payable to Executive by the Company in respect of his Employment
prior to the Termination Date pursuant to any agreement with the Company (other than this Agreement) or any Plan. 
  

	6.	Executive’s General Release and Resignation from Board of Directors 

 As a condition to the obligations of the Company to pay severance compensation and provide benefits pursuant to Section 3, the Company shall have received from Executive on the Termination Date a
written resignation from the Board and as an officer and director of the Company, the Group, all of its Affiliates and a general release up to the Termination Date in substantially the form of Exhibit A and updated as necessary to

  
 6 

 
reflect any changes in statutory references, relevant benefits plans as identified or such other changes as required, executed by Executive (the “Release”), and Executive shall not
thereafter seek to withdraw or in any way challenge to the effect or scope of the Release. If Executive fails to resign from the Board of the Company or any Affiliate by the Termination Date or fails to execute, or if Executive seeks to withdraw
from the Release or to in any way challenge the effect or scope, or acts in any way to suggest he is no longer bound by the Release, no payments or benefits shall thereafter be made or provided to Executive pursuant to this Agreement, and Executive
may be required to reimburse to the Company any payments or benefits received by Executive pursuant to this Agreement, but Executive’s obligations pursuant to this Agreement and Sections 7 and 8 in particular shall continue in force.

  

	7.	Confidential Information 

Executive acknowledges that, by reason of Executive’s employment by and service to the Company, Executive has had and will continue
to have access to confidential information of the Company, the Group and its Affiliates, including information and knowledge pertaining to products and services offered, innovations, designs, ideas, plans, trade secrets, proprietary information,
distribution and sales methods and systems, sales and profit figures, customer and client lists, and relationships between the Company, the Group and other distributors, customers, clients, suppliers and others who have business dealings with the
Company, the Group, and its Affiliates (“Confidential Information”). Executive acknowledges that such Confidential Information is a valuable and unique asset of the Company, and Group and Executive covenants that (except in connection with
the good faith performance of his duties while employed by the Company) Executive will not, either during or after Executive’s employment by the Company, disclose any such Confidential Information to any Person for any reason whatsoever without
the prior written authorization of the Company, unless such information is in the public domain through no fault of Executive or except as may be required by law or in a judicial or administrative proceeding. 

 

	8.	Restrictive Covenants 

  

	8.1	The Executive acknowledges: 

  

	 	(a)	that the Group is in a unique and highly specialised business; 

  

	 	(b)	that the Group’s market is international in scope with a limited number of competitors; 

 

	 	(c)	that the Group possess a valuable body of Confidential Information; 

  

	 	(d)	that the Group will give him access to Confidential Information in order to carry out his duties; 

  
 7 

	 	(e)	that the Executive’s duties include, without limitation, a duty of trust and confidence and a duty to act at all times in the best interests of the Group;

  

	 	(f)	that the Executive’s knowledge of Confidential Information directly benefits him by enabling him to perform his duties; 

 

	 	(g)	that unless required for the performance of his duties the disclosure of any Confidential Information to any actual or potential competitor of the Group will place the
Group at a serious competitive disadvantage and would cause immeasurable (financial and other) damage to the Relevant Business; 

  

	 	(h)	that if, on leaving the employment of the Company, he was to hold any position in any actual or potential competitor to the Relevant Business, it could place the Group
at a serious competitive disadvantage and would cause immeasurable (financial and other) damage to the Relevant Business. 

  

	8.2	Competition and Non-Solicitation 

For a period of 12 months (such period to be reduced by such period spent on garden leave) from the Termination Date, whether terminated
by the Company or by you, you shall not within the Restricted Area, without the prior written consent of the Company; 
  

	 	(a)	directly or indirectly in any capacity either on his own behalf or in conjunction with or on behalf of any other Person; 

 

	 	(i)	be engaged, concerned or interested in any capacity either on his own behalf or in conjunction with or on behalf of any other Person in the Relevant Business or in any
business wholly or partly in competition with the Relevant Business; 

  

	 	(ii)	solicit or entice or endeavour to solicit or entice away from the Company or any Affiliate or employ any Person who was employed in a senior executive, supervisory,
technical, sales or administrative capacity by the Company or any Affiliate, at any time during the 12 months preceding the Termination Date; 

  

	 	(iii)	directly or indirectly call on or solicit for the purpose of diverting or taking away from the Company or any Affiliate (including, by divulging any Confidential
Infomration to any competitor or potential competitor of the Company or any Affiliate) any Person who is at the Termination Date, or at any time during the twelve (12) month period prior to the Termination Date had been, a material or regular
customer of the Company or any Affiliate with whom you had direct personal contact as a representative of the Company or any Affiliate, or a potential material or regular customer whose identity is known to you at the Termination Date as one whom
the Company or any Affiliate was actively soliciting as a potential customer within six (6) months prior to the Termination Date ; 

  
 8 

	 	(iv)	interfere or seek to interfere or take steps as may interfere with the continuance of supplies to the Company or any Affiliate (or the terms relating to such supplies)
from any Persons who are or who have been supplying components, materials, goods or services to the Company or to any Affiliate at any time during the 12 month period immediately preceding the Termination Date; or 

 

	 	(v)	be engaged, concerned or interested in any Person who is or was at any time during the period of 12 months immediately preceding the Termination Date a significant or
regular customer of or supplier to the Company or any Affiliate, or who is or had been during the said 12 month period negotiating with the Company for the supply of a significant volume of services or goods, if such engagement, concern or interest
causes or would cause the supplier or customer to cease or materially to reduce its orders or contracts with, or the volume of goods and services received from the Company or any Affiliate. 

 

	8.3	You acknowledge and agree as follows: 

  

	 	(i)	that the restrictions set out in clause 8.2(a)(i) apply in the Restricted Area to Restricted Competitors only. 

 

	 	(iii)	that the list of Restricted Competitors does not represent the entirety of the market in which the Group and you are engaged and excludes a number of significant
multinational competitors covering the medical device industry and market, and as such, the restrictions set out in this clause 8 do not in any way impact on your ability to obtain employment outside of the Company or Group.

  

	8.4	The Executive agrees that if during the continuance in force of the restrictions set out in this clause 8, he receives an offer of employment from any person, he will
immediately provide that person with a complete and accurate copy of this clause 8. 

  

	8.5	You acknowledge that while it is the intention of the parties to this Agreement that the restrictions set out in this clause 8 are no greater than is necessary for the
protection of the interests of the Company and any Affiliate, nevertheless in the event that any of the said restrictions be adjudged to be invalid or unenforceable by any court of competent jurisdiction but would be adjudged fair and reasonable if
any part of the wording thereof were amended, modified, deleted or reduced in scope, then this clause 8 shall apply with such amendments, modifications, deletions and reductions in scope as may be necessary to make them valid and effective.

  

	8.6	Nothing contained in this clause 8 shall act to prevent the Executive from using generic skills learnt while employed by the Company in any business or activity which
is not in competition with the Company or Group. 

  
 9 

	8.7	The Executive acknowledges that he is subject to a separate but identical restriction in the Contract of Employment, which shall run in parallel with the restriction
contained in this Agreement and accepts that in the event that the restriction contained in this Agreement does not apply to him, or is deemed by a court of competent jurisdiction not to apply to him, that the restrictions contained in the Contract
of Employment shall continue to apply. 

  

	8.8	Return of Company and Group Property. 

 Upon a Termination of Employment Executive will deliver to the person designated by the Company all originals and copies of all documents and property of the Company and / or Group in Executive’s
possession, under Executive’s control, or to which Executive may have access. The Executive will not reproduce or appropriate for Executive’s own use, or for the use of others, any Confidential Information. 

 

	9.	Cooperation. 

 Upon Termination
of Employment, Executive shall reasonably cooperate with the Company, and / or the Group, and their officers, employees, agents, Affiliates and lawyers in the defense or prosecution of any lawsuit, dispute, investigation or other legal proceedings
or any preparation for any such disputes or proceedings that may be anticipated or threatened (“Proceedings”). Executive shall reasonably cooperate with the Company, and / or the Group, and their officers, employees, agents, Affiliates and
attorneys on any other matter (“Matters”) related to Company and/or Group business (specifically to include Teleflex Medical Incorporated and Arrow International, Inc. business) during the period in which Executive is employed by the
Company. Executive shall reasonably cooperate with the Company, and / or Group and their, officers, employees, agents, affiliates and lawyers in responding to any form of media inquiry or in making any form of public comment related to the
Executive’s employment, including, but not limited to, the Executive’s separation from the Company. Such cooperation shall include providing true and accurate information or documents concerning, or affidavits or testimony about, all or
any matters at issue in any Proceedings/Matters as shall from time to time be reasonably requested by the Company and / or Group, and shall be within Executive’s knowledge. Such cooperation shall be provided by Executive without remuneration,
but Executive shall be entitled to reimbursement for all reasonable vouched and appropriate expenses Executive incurs in so cooperating, including (by way of example not by way of limitation) reasonable airplane fares, hotel accommodations, meal
charges and other similar expenses to attend Proceedings/Matters outside of the island of Ireland. In the event Executive is made aware of any issue or matter related to the Company and / or Group, is asked by a third party to provide information
regarding the Company and / or Group, or is called other than by the Company as a witness to testify in any matter related to the Company and / or Group, Executive will notify the Company immediately in order to give the Company a reasonable
opportunity to respond and / or participate in such Proceeding/Matter, unless Executive is requested or required not to do so by law enforcement, or any other governmental agency or authority. 

  
 10 

	10.	Equitable and Other Relief; Consent to Jurisdiction of Irish Courts 

  

	(a)	Executive acknowledges that the restrictions contained in this Agreement are reasonable and necessary to protect the legitimate interests of the Company, the Group and
its Affiliates, that the Company would not have entered into this Agreement in the absence of such restrictions, and that any violation of any provision of these restrictions will result in irreparable injury to the Company and / or Group. Executive
represents and acknowledges that (i) Executive has been advised by the Company to consult Executive’s own legal counsel in respect of this Agreement and (ii) Executive has had full opportunity, prior to execution of this Agreement, to
review thoroughly this Agreement with Executive’s counsel. 

  

	(b)	Executive agrees that the Company and / or Group shall be entitled to preliminary and permanent injunctive relief, without the necessity of proving actual damages, as
well as an equitable accounting of all earnings, profits and other benefits arising from any violation of this Agreement, which rights shall be cumulative and in addition to any other rights or remedies to which the Company and / or Group may be
entitled under applicable law. Without limiting the foregoing, Executive also agrees that payment of the compensation and benefits payable under Section 3 may be automatically ceased in the event of a breach of the covenants of Sections 7 or 8
in particular. 

  

	11.	No Obligation to Mitigate Company’s Obligations 

 Executive will not be required to mitigate the amount of any payment or benefit provided for in this Agreement by seeking other employment or otherwise, nor shall the amount of any payment or benefit
provided for herein be reduced by any compensation earned by other employment or otherwise, except to the extent provided in Subsections 3(f) and 3(g). 
  

	14.	Deductions or Set-Offs. 

 The
Company reserves the right to make deductions in respect of all sums from time to time owed by you to the Company or any Affiliate, from your pay, bonus, allowances, expenses, or from any amounts which may be due to you by the Company pursuant to
this Agreement. By your agreeing to the terms and conditions set out in this letter you consent to the deduction of such sums. 

  
 11 

	15.	Notices 

 Save where otherwise
required by law, all notices and other communications given pursuant to or in connection with this Agreement shall be in writing and delivered (which may be by telefax or other electronic transmission) to a party at the following address, or to such
other address as such party may hereafter specify by notice to the other party: 
 If to the Company, to: 

Teleflex Medical Europe Ltd. 
 Garrycastle Business & Technology Park 
 Athlone 

Co. Westmeath, Ireland 
 Attention: General Counsel 
 If to Executive, to: 

Liam Kelly 

[ADDRESS INTENTIONALLY DELETED] 
  

	16.	Governing Law and Jurisdiction 

This Agreement shall be governed by and construed in accordance with the laws of Ireland and the courts of Ireland shall have exclusive
jurisdiction to deal with all disputes arising from or touching upon this Agreement. 
  

	17.	Parties in Interest 

 This
Agreement, including specifically the covenants of Sections 7 and 8, will be binding upon and inure to the benefit of the parties and their respective heirs, successors and assigns. 

 

	18.	Entire Agreement 

 This Agreement
and the Executive Change In Control Severance Agreement contain the entire agreement between the parties with respect to the right of Executive to receive severance compensation upon the termination of his Employment, and such Agreements supersede
any prior agreements or understandings between the parties relating to the subject matter of the Executive Change In Control Severance Agreement or this Agreement. 
 Where the Executive receives any benefit or payment provided for under this Agreement, he shall not be entitled to any benefit under the Executive Change In Control Severance Agreement and vice versa.
Under no circumstances may he be entitled to receive payment under both agreements. 
  

	19.	Amendment or Modification 

 No
amendment or modification of or supplement to this Agreement will be effective unless it is in writing and duly executed by the party to be charged thereunder. 
  

	20.	Construction 

  
 12 

 The following principles of construction will apply to this Agreement: 

 

	 	(a)	Unless otherwise expressly stated in connection therewith, a reference in this Agreement to a “Section,” “Exhibit” or “party” refers to a
Section of, or an Exhibit or a party to, this Agreement. 

  

	 	(b)	The word “including” means “including without limitation.” 

 

	21.	Headings and Titles 

 The
headings and titles of Sections and the like in this Agreement are inserted for convenience of reference only, form no part of this Agreement and shall not be considered for purposes of interpreting or construing any provision hereof. 

 

			
	EXECUTED as of the date first above written
	
	TELEFLEX MEDICAL EUROPE LTD.
		
	By:	 	 /s/ Gerard McCaffrey

	Name:	 	Gerard McCaffrey
	Title:	 	Director and Secretary

  

	
	EXECUTIVE:
	
	 /s/ Liam Kelly

	Liam Kelly

  
 13 

 EXHIBIT A 

GENERAL RELEASE 
 1. I, Liam Kelly, for and in consideration of certain payments to be made and the benefits to be provided to me under the Senior Executive Officer Severance Agreement, dated as of July
    2012 (the “Agreement”) between me and TELEFLEX MEDICAL EUROPE MEDICAL LIMITED (the “Company”) and conditioned upon such payments and provisions, do hereby REMISE, RELEASE, AND FOREVER DISCHARGE the
Company, the Group and each of its past or present subsidiaries and affiliates, its and their past or present officers, directors, stockholders, employees and agents, their respective successors and assigns, heirs, executors and administrators, the
pension and employee benefit plans of the Company, the Group or of its past or present subsidiaries or affiliates, and the past or present trustees, administrators, agents, or employees of the pension and employee benefit plans (hereinafter
collectively included within the term the “Company”), acting in any capacity whatsoever, of and from any and all manner of actions and causes of action, suits, debts, claims and demands whatsoever in law or in equity, which I ever had, now
have, or hereafter may have, or which my heirs, executors or administrators hereafter may have, by reason of any matter, cause or thing whatsoever from the beginning of my employment with the Company to the date of these presents and particularly,
but without limitation of the foregoing general terms, any claims arising from or relating in any way to my employment relationship and the termination of my employment relationship with the Company, including but not limited to, any claims which
have been asserted, could have been asserted, or could be asserted now or in the future under any local law, including any claims and for the avoidance of doubt, I waive and compromise any claim I may have against the Company or the Group arising
out of the constitution, contract, common law, in equity, statute (in particular, but not limited to the Unfair Dismissals Acts 1977–2007, the Minimum Notice and Terms of Employment Acts 1973–2007, the Organisation of Working Time Act
1997, the Redundancy Payments Acts 1967–2007, the Terms of Employment (Information) Acts 1994–2001, the Payment of Wages Act 1991, the Maternity Protection Acts 1994-2004 and the National Minimum Wage Act 2000, the Safety Health and
Welfare at Work Act 2005, the Employment Equality Acts 1998-2008, the Protection of Employment Act 1977, the Employees (Provision of Information and Consultation) Act 2006, the Protection of Employees (Part-Time) Work Act 2001, the Protection of
Employees (Fixed-Term) Work Act 2003, the Adoptive Leave Acts 1995-2005, the Carer’s Leave Act 2001, the Data Protection Acts 1988-2003, the European Communities (Protection of Employees on Transfer of Undertakings) Regulations 2003, the
Industrial Relations Acts 1948-2004, the Parental Leave Acts 1998 and 2006), the common law or otherwise all as amended, and all claims for counsel fees and costs; provided, however, that this Release shall not apply to any entitlements under the
terms of the Agreement or under the Company and / or Group plans [to be named and listed exhaustively, subject to clause 6 of the main agreement] in which I participated and under which I have accrued and become entitled to a benefit
(including indemnification and / or reimbursement to the extent provided under the Company’s Certificate of Incorporation, bylaws or applicable insurance policies) based on my actual service with the Company other than under any Company
separation or severance plan or programs. 

 Finally, I waive and compromise any claim to take a personal injuries claim against the
Company, the Group, any director, member or employee. 
 2. Subject to the limitations of paragraph 1 above, I expressly waive
all rights afforded by any statute which expressly limits the effect of a release with respect to unknown claims. I understand the significance of this release of unknown claims and the waiver of statutory protection against a release of unknown
claims. 
 3. I hereby agree and recognize that my employment by the Company was permanently and irrevocably severed on
            , 2    . I also hereby agree and recognize that I have resigned from my position as a member of the Board of Directors of the Company, the Group as well as
its subsidiaries and affiliates, on             , 2    . The Company and the Group have no obligation, contractual or otherwise to me to hire, rehire or reemploy me in
the future. I acknowledge that the terms of the Agreement provide me with payments and benefits which are in addition to any amounts to which I otherwise would have been entitled. 

4. I hereby agree and acknowledge that the payments and benefits provided to me by the Company are to bring about an amicable resolution
of my employment arrangements and are not to be construed as an admission of any violation of any law, or of any duty owed by the Company and that the Agreement was, and this Release is, executed voluntarily to provide an amicable resolution of my
employment relationship with the Company. 
 5. I hereby acknowledge that nothing in this Release shall prohibit or restrict me
from: making any disclosure of information required by law or as directed by the Company. In addition, I understand that each of the parties hereto (and each employee, representative, or other agent of such parties) may disclose to any person,
without limitation of any kind, the income tax treatment and tax structure of the transactions contemplated hereby and all materials (including opinions or other tax analyses) that are provided to such party relating to such tax treatment and tax
structure. 
 6. I hereby certify that I have read the terms of this Release, that I have been advised by the Company to discuss
it with my solicitor, that I have received the advice of counsel and that I understand its terms and effects. I acknowledge, further, that I am executing this Release of my own volition with a full understanding of its terms and effects and with the
intention of releasing all claims recited herein in exchange for the consideration described in the Agreement, which I acknowledge is adequate and satisfactory to me. None of the above named parties, nor their agents, representatives or attorneys
have made any representations to me concerning the terms or effects of this Release other than those contained herein. 

 7. I hereby further acknowledge that the terms of Sections 7 and 8 of the Agreement shall
continue to apply for the balance of the time periods provided therein and that I will abide by and fully perform such obligations. I further acknowledge that the payment due to me during the Severance Compensation Period are strictly subject to my
compliance (to the reasonable satisfaction of the Company) with the terms of this Agreement, but in particular Sections 7 and 8. 

8. This Release may be executed in one or more counterparts, including by facsimile signature, each of which shall be deemed to be an
original, but all of which shall be considered one and the same instrument. 
 Intending to be legally bound hereby, the Company and I execute
the foregoing Release as a Deed this         day of         , 20    . 

 

	
	PRESENT when the Common Seal of
	
	TELEFLEX MEDICAL EUROPE LIMITED.
	
	was affixed hereto:
	
	  

	
	Director
	
	  

	
	Director / Company Secretary

  

					
	 SIGNED and DELIVERED by Liam Kelly
	 	  
	 	
	 in the presence of:
	 		 	

  

					
	 Witness signature:
	 	  
	 	
			
	 Witness name :
	 	  
	 	
			
	 Witness address:EX-10.14

 Exhibit 10.14 

 
 EXECUTION COPY 

 
  

 
 EMPLOYMENT AGREEMENT 

 
 BETWEEN 

 
 CAREMORE HEALTH GROUP, INC. 

 
 AND 

 
 LEEBA LESSIN 

 
 FEBRUARY 28, 2006 

 
  

 EXECUTION COPY 

 
 THIS EMPLOYMENT AGREEMENT is made and entered into as
of February 28, 2006, and effective as of the Closing Date (as hereinafter defined), by and among CAREMORE HEALTH GROUP, INC., a California corporation (“Group” or the “Employer”), and LEEBA LESSIN
(the “Employee”). 
  

WHEREAS, pursuant to that certain Stock Purchase Agreement dated as of December 22, 2005 (the “Stock Purchase
Agreement”) among CareMore Medical Enterprises (“CME”). the CareMore Employee Stock Ownership Trust, CareMore Medical Group, Sheldon S. Zinberg, M.D., Donald Furman, M.D. and CareMore Holdings, Inc.
(“Holdings”). Holdings shall purchase all outstanding shares of the common stock and participating stock of CME, effective as of the “Closing Date” as defined in the Stock Purchase Agreement (the “Closing
Date”); 
  
 WHEREAS, effective as of
the Closing Date, the sole stockholder of CME shall be Holdings; the sole stockholder of Holdings shall be Group, and the sole stockholder of Group shall be CareMore, L.P., a Delaware limited partnership (the “Partnership”);

  
 WHEREAS, the Employer desires to employ
the Employee, and the Employee desires to accept such employment, on the terms and subject to the conditions hereinafter set forth; 
  

NOW, THEREFORE, in consideration of the covenants contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto agree as follows. 
  
 Section 1. Definitions. Generally, defined terms used in this Agreement are defined in the first instance in which they appear herein. In addition, the following terms and phrases shall
have the following meanings: 
  

“Affiliate” shall mean, when used with reference to a specified Person, (a) any Person who directly or indirectly
controls, is controlled by or is under common control with the specified Person, (b) any Person who is an officer, director, partner, member, manager or trustee of, or serves in a similar capacity with respect to, the specified Person, or for
which the specified Person is an officer, director, partner, member or manager or trustee or serves in a similar capacity, (c) any Person who, directly or indirectly, is the beneficial owner of 10% or more of any class of equity securities of
the specified Person, or of which the specified Person, directly or indirectly, is the owner of 10% or more of any class of equity securities and (d) any member of such specified Person’s immediate family. 

 
 “Board” shall mean the board of directors of
Group. 
  
 “Business Day” shall mean
any day that is not a Saturday, Sunday, or a day on which banking institutions in New York are not required to be open. 
  

“Cause” shall mean the Employee’s: 

 
 (i) failure to devote substantially all his
working time to the business of Group and its Affiliates; 

 (ii) willful disregard of his duties, or his intentional failure to act
where the taking of such action would be in the ordinary course of the Employee’s duties hereunder; 
  

(iii) gross negligence or willful misconduct in the performance of his duties hereunder; 

 
 (iv) commission of any act of fraud, theft
or financial dishonesty, or any felony or criminal act involving moral turpitude; or 
  

(v) unlawful use (including being under the influence) of alcohol or drugs or possession of illegal drugs while on the
premises of the Employer or any of its Affiliates or while performing duties and responsibilities to the Employer and its Affiliates. 
  

“Company” shall mean Group and its Subsidiaries; provided, that for purposes of Sections 9, 10, 11 and 12,
“Company” shall include Holdings and each of its Subsidiaries and Affiliates. 
  
 “Confidential Information” shall mean all proprietary and other information relating to the business and operations of Group and its Affiliates, which has not been specifically designated
for release to the public by an authorized representative of Group or one of its Affiliates, including, but not limited to the following: (i) information, observations, procedures and data concerning the business or affairs of the Group or any
of its Affiliates; (ii) products or services; (iii) costs and pricing structures; (iv) analyses; (v) drawings, photographs and reports; (vi) computer software, including operating systems, applications and program listings;
(vii) flow charts, manuals and documentation; (viii) data bases; (ix) accounting and business methods; (x) inventions, devices, new developments, methods and processes, whether patentable or unpatentable and whether or not
reduced to practice; (xi) customers, vendors, suppliers and customer, vendor and supplier lists; (xii) other copyrightable works; (xiii) all production methods, processes, technology and trade secrets and (xiv) all similar and related
information in whatever form. Confidential Information will not include any information that has been published in a form generally available to the public prior to the date the Employee proposes to disclose or use such information. Confidential
Information will not be deemed to have been published merely because individual portions of the information have been separately published, but only if all material features comprising such information have been published in combination. 

 
 “Disability” shall mean the Employee’s
inability, due to physical or mental illness or disability, to perform the essential functions of his employment with the Employer, even with reasonable accommodation that does not impose an undue hardship on the Employer, for more than sixty
(60) consecutive days, or for any ninety (90) days within any one year period, unless a longer period is required by federal or state law, in which case such longer period will be applicable. The Employer reserves the right, in good faith,
to make the determination of Disability under this Agreement based on information supplied by the Employee and/or his medical personnel, as well as information from medical personnel selected by the Employer or its insurers. 

  
 2 

 “Partnership Agreement” means that certain Limited Partnership Agreement of
CareMore, L.P., as in effect from time to time. 
  

“Person” shall be construed broadly and shall include, without limitation, an individual, a partnership, an investment
fund, a limited liability company, a corporation, an association, a joint stock company, a trust, a joint venture, an unincorporated organization and a governmental entity or any department, agency or political subdivision thereof. 

 
 “Subsidiary” or
“Subsidiaries” of any Person shall mean any corporation, partnership, joint venture or other legal entity of which such Person (either alone or through or together with any other Person), owns, directly or indirectly, 50% or more of
the stock or other equity interests which are generally entitled to vote for the election of the board of directors or other governing body of such corporation or other legal entity. 
  
 “Termination Date” shall mean the effective date of the termination of the Employee’s
employment hereunder, which (i) in the case of termination by resignation, shall mean the date that is ninety (90) days following the date of the Employee’s written notice to the Employer of his resignation; provided, however, that
the Employer may accelerate the Termination Date; (ii) in the case of termination by reason of death shall mean the date of death; (iii) in the case of termination by reason of Disability, shall mean the date specified in the notice of
such termination delivered to the Employee by the Employer; (iv) in the case of a Termination for Cause or a Termination without Cause, shall mean the date specified in the written notice of such termination delivered to the Employee by the
Employer; (iv) in the case of termination by mutual agreement shall mean the date mutually agreed to by the parties hereto and (v) in the case of nonrenewal, shall mean the next scheduled Renewal Date. 

 
 “Unitholder’s Agreement” shall mean
that certain Management Unitholder’s Agreement dated on or about the date hereof by and between the Partnership and the Employee. 
  

Section 2. Employment. The Employer shall employ the Employee, and the Employee accepts employment with the Employer, upon the terms
and conditions set forth in this Agreement. The initial term of this Agreement (the “Initial Term”) shall commence on the Closing Date and end on December 31, 2010; provided, however, that on December 31, 2010 and each
December 31 thereafter (each, a “Renewal Date”), the term of this Agreement shall be extended by one additional year (each, an “Extension Term,” and collectively with the Initial Term, the “Employment
Period”) unless either party gives written notice to the other within ninety (90) days in advance of the next scheduled Renewal Date that it does not wish to extend the Employment Period (such notice, a “Notice of
Nonrenewal”); and provided, further, that the Employment Period may be sooner terminated as provided herein. In the event that the transactions contemplated by the Stock Purchase Agreement are not completed and the Closing Date does not
occur, this Agreement shall be null and void ab initio. 
  

Section 3. Position and Duties. During the Employment Period, the Employee shall serve as Executive Vice President of Group, reporting
to the Board and the Chief Executive Officer of Group, and shall have the usual and customary duties, responsibilities and authority of such position, and, if elected or appointed thereto, shall serve as an officer and/or member of the board or any
Subsidiary or Affiliate of Group as reasonably requested by the Employer and its 

  
 3 

 
Affiliates, in each case, without additional compensation hereunder. The Employee hereby accepts such employment and positions and agrees to diligently and conscientiously devote his full and
exclusive business time, attention, and best efforts in discharging and fulfilling his duties and responsibilities hereunder. The Employee shall comply with the Employer’s policies and procedures and the direction and instruction of the Board
and the Employee shall not engage in any business activity which, in the reasonable judgment of the Board, conflicts with the duties of the Employee hereunder, whether or not such activity is pursued for gain, profit or other pecuniary advantage.

  
 Section 4. Compensation 

 
 (a) Salary. During the Employment Period, the
Employer shall pay the Employee base salary (the “Base Salary”) at the rate of $300,000 per annum, less applicable deductions and withholdings. 
  

(b) Performance Bonus. In addition to the Base Salary, during the Employment Period the Employee shall be eligible to receive a
cash bonus (the “Bonus”) with respect to each calendar year as of the last day of which the Employee is employed by the Employer. The amount of the Bonus, if any, payable in respect of any calendar year will be determined based on
the achievement of performance goals established for the Employee by the Board or compensation committee of the Board (the “Compensation Committee”) within the first ninety (90) days of such year (or with respect to the first
calendar year hereunder, within the first thirty (30) days of the commencement of the Employment Period) (the “Performance Targets”). The target Bonus (the “Target Bonus Percentage”) and the maximum Bonus (the
“Maximum Bonus Percentage”) in respect of each calendar year will equal 16.5% and 33%, respectively, of the Base Salary paid or payable to the Employee for such year. Performance Targets may be based on quantitative performance
objectives for Group or one or more of its Affiliates or Subsidiaries or business units or divisions thereof, and/or may be based on individual quantitative or qualitative performance objectives or any combination of the foregoing. The calculation
of the achievement of Performance Targets for each year shall be determined by the Board or Compensation Committee in its good faith discretion. The Bonus, if any, payable with respect to a calendar year shall be paid within thirty (30) days
following the rendering of Group’s audited financial statements for the relevant calendar year. The general guidelines for the Performance Targets and calculation of the Bonus that may be payable for calendar year 2006 are specified on
Exhibit A attached hereto. 
  
 (c) Benefits
and Perquisites. Additional benefits and perquisites will be provided subject to Group’s policies and practices and the terms of applicable benefit plans and arrangements as in effect from time to time. 

 
 (d) Reimbursements. The Employer shall reimburse the
Employee for all reasonable and necessary business-related expenses incurred by him in the course of performing his duties under this Agreement which are consistent the Employer’s policies in effect from time to time with respect to travel,
entertainment and other business expenses, subject to the Employer’s requirements with respect to reporting and documentation of such expenses. 

  
 4 

 (e) Deductions and Withholding. The Employer shall deduct from any payments to be
made by it to or on behalf of the Employee under this Agreement any amounts required to be withheld in respect of any federal, state or local income or other taxes. 

 
 (f) Annual Review of Base Salary and Bonus
Percentages. The Board (or the Compensation Committee) shall undertake a review of rate of Base Salary and the Target Bonus Percentage and Maximum Bonus Percentage (the “Bonus Percentages”) not less frequently than annually
during the Employment Period and may increase, but not decrease, the rate of Base Salary and the Bonus Percentages from those then in effect. 
  

Section 5. Termination of Employment. The Employee’s employment under this Agreement shall be terminated upon the earliest to
occur of the following events: 
  
 (a)
Termination for Cause. The Employer may in its sole discretion terminate this Agreement and the Employee’s employment hereunder for Cause at any time and with or without advance notice to the Employee. 

 
 (b) Termination without Cause. The Employer may
terminate this Agreement and the Employee’s employment hereunder without Cause at any time, with or without notice, for any reason or no reason (and no reason need be given). 

 
 (c) Mutual Agreement. This Agreement and the
Employee’s employment hereunder may be terminated by the mutual written agreement of the Employer and the Employee. 
  

(d) Termination by Death or Disability. This Agreement and the Employee’s employment hereunder shall automatically terminate
upon the Employee’s death or Disability. 
  

(e) Resignation. The Employee may terminate this Agreement and his employment hereunder upon ninety (90) days advance written
notice to the Employer. 
  
 (f) Nonrenewal.
In the event either party delivers to the other a Notice of Nonrenewal, this Agreement and the Employee’s employment hereunder shall automatically terminate as of the next scheduled Renewal Date. 

 
 Section 6. Compensation upon Termination 

 
 (a) General. In the event of the Employee’s
termination of employment for any reason, the Employee or his estate or beneficiaries shall have the right to receive the following: 
  

(i) the unpaid portion of the Base Salary and paid time off accrued and payable through the Termination Date; 

 
 (ii) reimbursement for any expenses for
which the Employee shall not have been previously reimbursed, as provided in Section 4(d); and 
  

(iii) continuation of health insurance coverage rights, if any, as required under applicable law. 

  
 5 

 (b) Termination for Cause, Resignation, Mutual Agreement or Nonrenewal. In the event
of the Employee’s termination of employment by reason of (i) Termination for Cause, (ii) Resignation, (iii) Mutual Agreement or (iv) Nonrenewal, the Employer shall have no current or further obligations (including Base
Salary) to the Employee under this Agreement other than as set forth in Section 6(a). 
  
 (c) Termination without Cause or by Death or Disability. Subject to Section 6(d), in the event of the Employee’s termination of employment hereunder by reason of
(i) Termination without Cause or (ii) death or Disability, the Employee shall be entitled to the following (the “Severance Benefits”); 

 
 (i) a lump sum equal to rate of Base Salary
in effect upon the Termination Date, payable within fifteen (15) days following the Termination Date; 
  

(ii) a pro rata amount of the Bonus, if any, which would have been payable to the Employee for the calendar year in which
the Termination Date occurs, determined after the end of the calendar year in which such Termination Date occurs and equal to the amount which would have been payable to the Employee if his employment had not been terminated during such calendar
year multiplied by the fraction, the numerator of which is the number of whole months the Employee was employed by the Employer during such calendar year and the denominator of which is 12. Any pro rata bonus payable under this
Section 6(c)(ii) shall be paid in a lump sum at the time bonuses for such calendar year are otherwise payable to senior executives of the Employer; and 

 
 (iii) in the event that the Employee elects
COBRA benefits, the Employer shall pay the Employee’s share of the premium for such COBRA benefits until the earlier of (i) one year after the Termination Date; or (ii) the date that Employee obtains comparable health benefits through
new employment. 
  
 (d) General Release.
Notwithstanding any provision to the contrary in this Agreement, the foregoing Severance Benefits under Section 6(c) shall not apply and the Employer shall have no obligations to pay or provide any Severance Benefits (other than upon the
Employee’s termination of employment by reason of death), unless the Employee signs, delivers and does not rescind or revoke a general release, substantially in the form attached hereto as Exhibit B, of all known and unknown claims of
the Employee (and his affiliates, successors, heirs and assigns and the like) against Group, the Board and all Affiliates of Group. 
  

(e) The rights of the Employee set forth in this Section 6 are intended to be the Employee’s exclusive remedy for
termination and, to the greatest extent permitted by applicable law, the Employee waives all other remedies. 
  
 Section 7. Insurance. Group or one of its Affiliates may, for its own benefit, maintain “key man” life and disability insurance policies covering the Employee. The Employee
will cooperate with Group or its Affiliates and provide such information or other assistance as they may reasonably request in connection with obtaining and maintaining such policies. 

  
 6 

 Section 8. Exclusive Services. During the term of this Agreement, the Employee will not
accept or perform any work, consulting, or other services for any other business entity or for remuneration of any kind, without written approval by the Board. 
  

Section 9. The Employee’s Termination Obligations. The Employee hereby acknowledges and agrees that all personal property and
equipment furnished to or prepared by the Employee in the course of or incident to his employment hereunder belongs to the Company and shall be promptly returned to the Company upon termination of the Employee’s employment. The term
“personal property” includes, without limitation, all office equipment, laptop computers, cell phones, books, manuals, records, reports, notes, contracts, requests for proposals, bids, lists, blueprints, and other documents, or materials,
or copies thereof (including computer files), and all other proprietary and non-proprietary information relating to the business of the Company. Following termination of his employment hereunder, the Employee will not retain any written or other
tangible material containing any proprietary or non-proprietary information of the Company. 
  
 Section 10. Acknowledgment of Protectable Interests. The Employee acknowledges and agrees that his employment with Group involves building and maintaining business relationships and
good will on behalf of the Company with customers, patients, physicians and other professional contractors, employees and staff, and various providers and users of health care services; that he is entrusted with proprietary, strategic and other
confidential information which is of special value to Company; and that the foregoing matters are significant interests which the Company is entitled to protect. 

 
 Section 11. Confidential Information. The Employee agrees
that all Confidential Information that comes or has come into his possession by reason of his employment hereunder is the property of the Company and shall not be used except in the course of employment by the Company and for the Company’s
exclusive benefit. Further, the Employee shall not, during his employment or thereafter, disclose or acknowledge the content of any Confidential Information to any person who is not an employee of the Company authorized to possess such Confidential
Information. Upon termination of employment, the Employee shall deliver to Group all documents, writings, electronic storage devices, and other tangible things containing any Confidential Information and the Employee shall not make or retain copies,
excerpts, or notes of such information. 
  
 Section 12.
Nonsolicitation/Nondisparagement. In the event of the termination of this Agreement for any reason, the Employee shall not, for a period of one (1) year thereafter, directly or indirectly: 

 
 (a) solicit, induce or encourage any employee of the Company
to terminate his or her employment with the Company; 
  
 (b) make any disparaging public statement concerning the Company; or 
  

(c) use the Company’s Confidential Information to induce, attempt to induce or knowingly encourage any Customer (as defined below) of
the Company to divert any business or income from the Company, or to stop or alter the manner in which they are then doing business 

  
 7 

 with the Company. The term “Customer” with respect to the Company shall mean any individual or
business firm that is, or within the prior twenty-four (24) months was, a customer or client of the Company, or whose business was actively solicited by the Company at any time, regardless of whether such customer was generated, in whole or in
part, by the Employee’s efforts. 
  
 Section 13.
Damages For Improper Termination With Cause. In the event that the Employer terminates this Agreement and the Employee’s employment hereunder for “Cause,” but it subsequently is determined by an arbitrator or a court of
competent jurisdiction, as the case may be, that the Employer did not have Cause for the termination, then for purposes of this Agreement, the Employer’s decision to terminate shall be deemed to have been a termination without Cause, and the
Employer shall be obligated to pay the Severance Benefits specified under Section 6(c), and only that amount. 
  

Section 14. Arbitration. Any controversy or dispute arising out of, based upon, or relating to this Agreement, its enforcement or
interpretation, or because of an alleged breach, default, or misrepresentation in connection with any of its provisions, or arising out of, based upon, or relating in any way to the Employee’s employment or association with the Company, or
termination of the same, including, without limiting the generality of the foregoing, any questions regarding whether a particular dispute is arbitrable, and any alleged violation of statute, common law or public policy, including, but not limited
to, any state or federal statutory claims, shall be submitted to final and binding arbitration in Orange County, California, in accordance with the JAMS Employment Arbitration Rules and Procedures, before a single neutral arbitrator selected from
the JAMS panel, or if JAMS is no longer able to supply the arbitrator, such arbitrator shall be selected from the American Arbitration Association, in accordance with its National Rules for the Resolution of Employment Disputes (the arbitrator
selected hereunder, the “Arbitrator”). Provisional injunctive relief may, but need not, be sought by either party to this Agreement in a court of law while arbitration proceedings are pending, pursuant to California Code of Civil
Procedure section 1281.8, and any provisional injunctive relief granted by such court shall remain effective until the matter is finally determined by the Arbitrator. Final resolution of any dispute through arbitration may include any remedy or
relief which the Arbitrator deems just and equitable, including any and all remedies provided by applicable state or federal statutes. At the conclusion of the arbitration, the Arbitrator shall issue a written decision that sets forth the essential
findings and conclusions upon which the Arbitrator’s award or decision is based. Any award or relief granted by the Arbitrator hereunder shall be final and binding on the parties hereto and may be enforced by any court of competent
jurisdiction. The parties acknowledge and agree that they are hereby waiving any rights to trial by jury in any action, proceeding or counterclaim brought by either of the parties against the other in connection with any matter whatsoever arising
out of or in any way connected with this Agreement or the provision of services under this Agreement. The Employer will pay the arbitrator’s fees and arbitration expenses and any other costs associated with the arbitration or arbitration
hearing that are unique to arbitration. Subject to the provisions of Section 25, the parties shall each pay their own deposition, witness, expert and attorneys’ fees and other expenses as and to the same extent as if the matter were
being heard in court. 

  
 8 

 Section 15. Representations/Warranties. The Employee represents and warrants that he is
under no contractual or other obligation that would prevent him from accepting the Employer’s offer of employment as set forth herein. 
  

Section 16. Entire Agreement. This Agreement is intended by the parties to be the final expression of their agreement with respect to
the employment of the Employee by the Company and may not be contradicted by evidence of any prior or contemporaneous agreement (including, without limitation any term sheet or similar agreement entered into between the Company or any Affiliate and
the Employee). The parties further intend that this Agreement shall constitute the complete and exclusive statement of its terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding
to vary the terms of this Agreement. 
  
 Section 17. No
Representations. No person or entity has made or has the authority to make any representations or promises on behalf of any of the parties which are inconsistent with the representations or promises contained in this Agreement, and this
Agreement has not been executed in reliance on any representations or promises not set forth herein. Specifically, no promises, warranties or representations have been made by anyone on any topic or subject matter related to the Employee’s
relationship with the Employer or any of its Affiliates or any of their executives or employees, including but not limited to any promises, warranties or representations regarding future employment, compensation, benefits, any entitlement to equity
interests in Group or any of its Affiliates or regarding the termination of the Employee’s employment. In this regard, the Employee agrees that no promises, warranties or representations shall be deemed to be made in the future unless they are
set forth in writing and signed by an authorized representative of the Employer. 
  
 Section 18. Amendments. This Agreement may be modified only by agreement of the parties by a written instrument executed by the parties that is designated as an amendment to this
Agreement. 
  
 Section 19. Severability and
Non-Waiver/Survival. Any provision of this Agreement (or portion thereof) which is deemed invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction and subject to this Section 19, be ineffective to the
extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions thereof in such jurisdiction or rendering such provision or any other provision of this Agreement invalid, illegal, or unenforceable in
any other jurisdiction. If any covenant should be deemed invalid, illegal or unenforceable because its scope is considered excessive, such covenant shall be modified so that the scope of the covenant is reduced only to the minimum extent necessary
to render the modified covenant valid, legal and enforceable. No waiver of any provision or violation of this Agreement by the Employer shall be implied by the Employer’s forbearance or failure to take action. The expiration or termination of
the Employment Period and this Agreement shall not impair the rights or obligations of any party hereto which shall have accrued hereunder prior to such expiration or termination. 

 
 Section 20. Successor/Assigns. This Agreement shall be
binding upon and inure to the benefit of the parties and their respective heirs, representatives, executors, administrators, successors, and assigns, provided, however, that the Employee may not assign any or all of his 

  
 9 

 rights or duties hereunder except following the prior written consent of the Employer. The Employee shall be
entitled, to the extent permitted under applicable law, to select and change a beneficiary or beneficiaries to receive any compensation or benefit hereunder following the Employee’s death by giving written notice thereof. In the event of the
Employee’s death or a judicial determination of his incompetence, references in this Agreement to the Employee shall be deemed, where appropriate, to refer to his beneficiary, estate or other legal representative. 

 
 Section 21. Voluntary and Knowledgeable Act. The Employee
represents and warrants that the Employee has read and understands each and every provision of this Agreement and has freely and voluntarily entered into this Agreement. 

 
 Section 22. Choice of Law. This Agreement shall be
governed as to its validity and effect by the laws of the state of California without regard to principles of conflict of laws. 
  

Section 23. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but both of
which together shall constitute one and the same instrument. 
  

Section 24. Notices. All notices and other communications necessary or contemplated under this Agreement shall be in writing and shall
be delivered in the manner specified herein or, in the absence of such specification, shall be deemed delivered when delivered in person or sent by first-class mail (certified or registered mail, return receipt requested, postage prepaid), facsimile
or overnight air courier guaranteeing next day delivery, addressed as follows: 
  

					
	(a)	 	if to the Employee, to him at his most recent address in the Employer’s records,
			
		 	with a copy to:	  	 Rutan & Tucker
 611 Anton
Boulevard
 Fourteenth Floor
 Costa
Mesa, California 92626-1931
 Facsimile: (714) 546-9035
 Attention: George J. Wall, Esq.

			
	(b)	 	if to the Employer, to:	  	 CareMore Health Group, Inc.

c/o CareMore Holdings, Inc.
 1071 Camelback
Street, Suite 111
 Newport Beach, California 92660
 Facsimile: (949) 464-0501
 Attention: Corporate Secretary

			
		 	with a copy to:	  	 J.P. Morgan Partners (BHCA), L.P.
 1221 Avenue of the Americas, 39th Floor
 New York, New York 10020

Facsimile: (917) 464-7465
 Attention: Official
Notices Clerk
 FBO: Kevin O’Brien

  
 10 

					
			
		 		  	 and:
  

Latham & Watkins LLP
 885 Third
Avenue
 New York, New York 10022

Facsimile: (212) 751-4864
 Attention:
Maureen A. Riley

  
 or to such other address as the recipient
party to whom notice is to be given may have furnished to the other party in writing in accordance herewith. 
  
 Section 25. Attorneys’ Fees. In the event that any dispute between the parties should result in litigation or arbitration, the prevailing party in such dispute shall be entitled to
recover from the other party all reasonable fees, costs and expenses of enforcing any right of the prevailing party, including without limitation, reasonable attorneys’ fees and expenses, all of which shall be deemed to have accrued upon the
commencement of such action and shall be paid whether or not such action is prosecuted to judgment. Any judgment or order entered in such action shall contain a specific provision providing for the recovery of attorneys’ fees and costs incurred
in enforcing such judgment and an award of prejudgment interest from the date of the breach at the maximum rate of interest allowed by law. For the purposes of this Section 25: (a) attorneys’ fees shall include, without
limitation, fees incurred in the following: (i) postjudgment motions; (ii) contempt proceedings; (iii) garnishment, levy, and debtor and third party examinations; (iv) discovery and (v) bankruptcy litigation and
(b) “prevailing party” shall mean the party who is determined in the proceeding to have prevailed or who prevails by dismissal, default or otherwise. 

 
 Section 26. Descriptive Headings; Nouns and Pronouns.
Descriptive headings are for convenience only and shall not control or affect the meaning or construction of any provision of this Agreement. Whenever the context may require, any pronouns used herein shall include the corresponding masculine,
feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural and vice-versa. 
  
 Section 27. Non-Qualified Deferred Compensation. The parties acknowledge and agree that, to the extent applicable, this Agreement shall be interpreted in accordance with
Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other
guidance that may be issued after the date hereof. Notwithstanding any provision of this Agreement to the contrary, in the event that the Employer determines that any amounts payable hereunder will be immediately taxable to the Employee under
Section 409A of the Code and related Department of Treasury guidance, the Employer may (a) adopt such amendments to this Agreement and appropriate policies and procedures, including amendments and policies with retroactive effect, that the
Employer determines necessary or appropriate to preserve the intended tax treatment of the benefits provided by this Agreement and/or (b) take such other actions as the Employer determines necessary or appropriate to comply with the requirements of
Section 409A of the Code and related 

  
 11 

 Department of Treasury guidance, including such Department of Treasury guidance and other interpretive
materials as may be issued after the date hereof. 
  

Section 28. Waiver of Jury Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION,
PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT. 
  
 [signature page follows] 

  
 12 

 IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of
the date first written above. 
  

			
	CAREMORE HEALTH GROUP, INC.
		
	 By:
	 	

		 	 Name:

		 	 Title:

	
	 

	Leeba Lessin, individually

  

 EXHIBIT A 

 
 Guidelines for 2006 Bonus 

 
 [spreadsheet attached] 

 CareMore Health Group, Inc. 
 2006 Annual Incentive Plan 

 

  
  

					
	 EXECUTIVE:
	 	 	Leeba Lessin	  
	 BASE SALARY:
	 	$	300,000	  
		
	 MAXIMUM BONUS

PERCENTAGE:
	 	 	33	% 

 

 CRITERIA 
  
 I. EBITDA (in millions)
  

																					
	 	 	(IN MILLIONS)	 	  	% of MAX*	 	 	% of Base*	 	 	Weighting*	 	 	Payout*	 
	 MINIMUM
	 	$	40.00	  	  	 	0	% 	 	 	0	% 	 	 	65	% 	 	$	—  	  
	 TARGET
	 	$	45.00	  	  	 	50	% 	 	 	16.50	% 	 	 	65	% 	 	$	32,175	  
	 MAXIMUM
	 	$	50.00	  	  	 	100	% 	 	 	33.00	% 	 	 	65	% 	 	$	64,350	  
		
	II. Membership Growth (in number of lives)	  	 			
						
	 	 	 	 	  	% of MAX	 	 	% of Base	 	 	Weighting	 	 	Payout	 
	 MINIMUM
	 	 	8,000	  	  	 	0	% 	 	 	0	% 	 	 	20	% 	 	$	—  	  
	 TARGET
	 	 	10,000	  	  	 	50	% 	 	 	17	% 	 	 	20	% 	 	$	9,900	  
	 MAX
	 	 	12,000	  	  	 	100	% 	 	 	33	% 	 	 	20	% 	 	$	19,800	  
		
	III. New Market Entry-SNP	  	 			
						
	 	 	 	 	  	% of MAX	 	 	% of Base	 	 	Weighting	 	 	Payout	 
	 MINIMUM
	 	 	—  	  	  	 	0	% 	 	 	0.00	% 	 	 	15	% 	 	$	—  	  
	 TARGET
	 	 	1.00	  	  	 	100	% 	 	 	33.00	% 	 	 	15	% 	 	$	14,850	  
	 MAXIMUM
	 	 	1.00	  	  	 	100	% 	 	 	33.00	% 	 	 	15	% 	 	$	14,850	  

  
 Maximum Potential Bonus At
Maximum Achievement of, $ 99,000 
  

IV. MCR 
  

			
	< 70%	  	No Adjustment
	70% or Above	  	20% Reduction to otherwise payable Bonus

 
 

  

	*	Straight line interpolation between 0% and 50% for actual EBITDA between Minimum and Target; straight line interpolation between 50% and 100% for EBITDA between Target
and Maximum. 

 Notes and Definitions for Guidelines of 2006 Bonus 

 

	1.	The attached spreadsheet shows the percentage of the maximum bonus payable for each performance criteria at minimum, target and maximum goals and the weighting factor
applied to such criteria, before application of the MCR test below. If the actual performance for any criteria is less than the minimum goal for that criteria, the bonus payable with respect to such criteria will be zero. Regardless of the actual
performance with respect to any criteria, in no event will more than 100% of the maximum bonus percentage be payable in respect of such criteria. 

  

	2.	The aggregate amount of bonus, if any, payable with respect to all criteria other than MCR will be reduced by 20% if MCR equals or exceeds 70%.

  

	3.	“EBITDA” means, for the calendar year 2006 with respect to CareMore Health Group, Inc. (“Group”) and all on a consolidated basis,
Group’s net income plus (i) the sum of: (A) provision for taxes based on income, profits or capital of Group, including, without limitation, state, franchise and similar taxes; (B) interest expense; (C) depreciation and
amortization expense; (D) business optimization expenses and other restructuring charges; (E) any other non-cash charges, provided that, for purposes of this clause (E), any non-cash charges or losses shall be treated as cash charges or
losses in any subsequent period during which cash disbursements attributable thereto are made, and (F) any fees paid to Blue Shield that relate to the transfer of lives from the Blue Shield healthcare plans to Group healthcare plans, minus
(ii) the sum (without duplication and to the extent the amounts described in this clause (ii) increased consolidated net income for the period for which EBITDA is being determined) of the non-cash charges increasing consolidated net income
for such period (but excluding any such charges (x) in respect of which cash was received in a prior period or will be received in a future period or (y) which represent the reversal of any accrual of, or cash reserve for, anticipated cash
charges in any prior period). For the purposes of this definition “Blue Shield” means California Physicians’ Service, Inc., d.b.a. Blue Shield of California. 

  

	4.	“Membership Growth” means the excess, if any, of (x) the number of persons enrolled in Medicare Advantage as of January 1, 2007, over (y) the number
of persons enrolled in Medicare Advantage as of January 1, 2006, excluding for this purpose persons who become enrolled due to the development by Group or its Subsidiaries of a special needs business whether by merger, acquisition or internal
product development or any other means. 

  

	5.	“New Market Entry-SNP” means, as of December 31,2006, the number of new “special needs population” markets (i) which have been
specifically identified by Group or a Subsidiary, (ii) for which licensure procedures by Group or a Subsidiary are substantially underway and (iii) for which a delivery system has been substantially developed by Group or any Subsidiary.

  

	6.	“MCR” means the annual average “medical cost ratio” for Group for calendar year 2006. 

  
 A-2

 EXHIBIT B 

 
 [Form of Release] 

 
 1. [Severance Benefits] 

 
 2. Release of Claims. Except as explicitly provided
below, you agree that the foregoing consideration represents settlement in full of all outstanding obligations owed to you by the Company, and its respective officers, directors, partners, members, agents and employees, including, without
limitation, any and all obligations under the Employment Agreement, and is satisfactory consideration for the waiver and release of all claims set forth herein. On behalf of yourself, and your respective heirs, family members, executors and assigns,
you hereby fully and forever release the Company and its past, present and future officers, agents, directors, employees, investors, stockholders, partners, members, administrators, affiliates, divisions, subsidiaries, parents, predecessor and
successor corporations and assigns (the “Releasees”), from, and agree not to sue concerning, or in any manner to institute, prosecute or pursue, or cause to be instituted, prosecuted, or pursued, any claim, duty, obligation or cause
of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that you may possess against any of the Releasees arising from any omissions, acts or facts that
have occurred up until and including the Effective Date of this Release including, without limitation: 
  

(a) any and all claims relating to or arising from your employment relationship with the Company and the termination of that relationship;

  
 (b) any and all claims relating to, or arising
from, your right to purchase, or actual purchase of shares of stock or other securities of the Company or any of its affiliates or subsidiaries, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach
of duty under applicable state corporate law, and securities fraud under any state or federal law; 
  
 (c) any and all claims for wrongful discharge of employment; termination in violation of public policy; discrimination; harassment; retaliation; breach of contract, both express and implied, including,
without limitation, any and all claims arising under or in connection with the Employment Agreement; breach of a covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of emotional
distress; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander; negligence; personal injury; assault; battery;
invasion of privacy; false imprisonment; and conversion; 
  
 (d) any and all claims for violation of any federal, state or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Age
Discrimination in Employment Act of 1967; the Americans with Disabilities Act of 1990; the Fair Labor Standards Act; the Employee Retirement Income Security Act of 1974; The Worker Adjustment and Retraining Notification Act; the Family and Medical
Leave Act; the California Fair Employment and Housing Act; the California Family Rights Act; and the California Labor Code, including, but not limited to Section 201, et seq., Section 970, et seq., Sections 1400-1408; and all
amendments to each such Act as well as the regulations issued thereunder; 

  
 B-1

 (e) any and all claims for violation of the federal, or any state, constitution; 

 
 (f) any and all claims arising out of any other laws and
regulations relating to employment or employment discrimination; and 
  
 (g) any and all claims for attorneys’ fees and costs; 
  
 provided, however, that the parties hereto agree and acknowledge that you have not, by virtue of this Release or otherwise, waived any claim, duty, obligation or cause of action relating to any of
the following: 
  
 1) any matter that arises after
the Effective Date of this Release; 
  
 2) vested
benefits under any employee benefit plan within the meaning of section 3(3) of the Employee Retirement Income Security Act of 1974, as amended; 
  

3) any claim relating to indemnification in accordance with applicable laws or the Company’s certificate of incorporation or by-laws
or any applicable insurance policy, with respect to any liability as a director, officer or employee of the Company (including as a trustee, director or officer of any employee benefit plan); 
  
 4) any right to obtain contribution as permitted by law in the event of entry of judgment against you as a
result of any act or failure to act for which the Company and you are held jointly liable; and 
  
 5) any of your rights as a Limited Partner of Partnership under the Partnership Agreement and any rights under the Unitholder’s Agreement. 
  
 You agree that the release set forth in this Paragraph shall be and remain in effect in all respects as a
complete general release as to the matters released. This release does not extend to any obligations incurred under this Release. In the event that any of the parties brings an action to enforce or effect their rights under this Release, the
prevailing party shall be entitled to recover their reasonable attorneys’ fees and expenses incurred in connection with such an action. 
  

3. Acknowledgment of Waiver of Claims under ADEA. You acknowledge that you are waiving and releasing any rights you may have under
the Age Discrimination in Employment Act of 1967 (“ADEA”) and that this waiver and release is knowing and voluntary. You and the Company agree that this Release does not apply to any rights or claims that may arise under ADEA after
the Effective Date of this Release. You acknowledge that the consideration given for this Release is in addition to anything of value to which you were already entitled. You further acknowledge that you have been advised by this writing that:

  
 (a) you should consult with an attorney
prior to executing this Release; 

  
 B-2

 (b) you have up to [        ] days within which to
consider this Release; 
  
 (c) you have seven days
following your execution of this Release to revoke this Release; and this Release shall not be effective until the eighth day after you execute and do not revoke this Release; nothing in this Release prevents or precludes you from challenging or
seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs from doing so, unless specifically authorized by federal law. 

 
 Any revocation must be in writing and delivered to the
Company as follows: 
  

[                    
] by close of business on or before the seventh day from the date that you sign this Release. 
  
 4. Civil Code Section 1542/Unknown Claims. You represent that you are not aware of any claims against the Company other than the claims that are released by this Release. You acknowledge that
you have had the opportunity to be advised by legal counsel and are familiar with the provisions of California Civil Code 1542, below, which provides as follows: 

 
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE
CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR. 

 
 Being aware of said code section, you agree to expressly
waive any rights you may have thereunder, as well as under any statute or common law principles of similar effect. 
  

5. No Pending or Future Lawsuits. You represent that you have no lawsuits, claims, or actions pending in your name, or on behalf of
any other person or entity, against the Company or any of the Releasees. You also represent that you do not intend to bring any claims on your own behalf or on behalf of any other person or entity against the Company or any of the Releasees.

  
 6. Confidentiality of Release. You agree
to keep the terms of this Release in the strictest confidence and, except as required by law, not reveal the terms of this Release to any persons except your immediate family, your attorney, and your financial advisors (and to them only provided
that they also agree to keep the information completely confidential), and the court in any proceedings to enforce the terms of this Release. 
  

7. Non-Disparagement. You agree not to make any public oral or written statement, or take any other public action, that disparages
or criticizes the Company’s management, employees, products or services, in any case that damages the Company’s reputation or impairs its normal operations. 

 
 8. Entire Agreement. The terms of which are
specifically incorporated herein, this Release constitutes the entire agreement between you and the Company concerning your employment with and separation from the Company and all the events leading thereto and associated therewith, and supercedes
and replaces any and all prior agreements and understandings, both written and oral, concerning your relationship with the Company. 

  
 B-3

 9. Successors and Assigns. This Release shall be binding upon each of the parties and
upon their respective heirs, administrators, representatives, executors, successors and assigns, and shall inure to the benefit of each party and to their heirs, administrators, representatives, executors, successors, and assigns. 

 
 10. No Admission of Liability. You understand and
acknowledge that this Release constitutes a compromise and settlement of any and all potential disputed claims. No action taken by the Company hereto, either previously or in connection with this Release, shall be deemed or construed to be:
(a) an admission of the truth or falsity of any potential claims; or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to you or to any third party. 

 
 11. Authority. The Company represents and warrants
that the undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Release. Similarly, you represent and warrant that you have the capacity to act on
your own behalf and on behalf of all who might claim through you to bind them to the terms and conditions of this Release. The Company and you each warrant and represent that there are no liens or claims of lien or assignments in law or equity or
otherwise of or against any of the claims or causes of action released herein. 
  
 12. Effective Date. This Release is effective after it has been signed by both parties and after seven days have passed since you have signed this Release (such date, the “Effective
Date”). 
  
 13. Voluntary Execution of
Release. This Release is executed voluntarily and without any duress or undue influence on the part or behalf of the parties hereto, with the full intent of releasing all claims except claims specifically excluded under Paragraph 4 hereof. The
parties acknowledge that: 
  
 (a) They have read this
Release; 
  
 (b) They have been represented in the
preparation, negotiation, and execution of this Release by legal counsel of their own choice or that they have voluntarily declined to seek such counsel; 
  

(c) They understand the terms and consequences of this Release and of the releases it contains; and 

 
 (d) They are fully aware of the legal and binding effect of
this Release. The laws of the State of California govern this Release, regardless of the laws that might otherwise govern under applicable principles of conflict of law thereof. In the event that any portion of this Release or the application
thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Release will continue in full force and effect and the application of such portion to other persons or circumstances
will be interpreted so as reasonable to effect the intent of the parties hereto. This Release may not be modified, amended, altered or supplemented except by the execution and delivery of a written agreement executed by you and an authorized
representative of the Company or by a court of competent jurisdiction. 

  
 B-4

 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT 

AND NON-COMPETITION AGREEMENT 
  

(Amends and Restates First Amendment) 
  

This SECOND AMENDMENT TO THE EMPLOYMENT
AGREEMENT AND NON-COMPETITION AGREEMENT (this “Second Amendment”) is entered into as of August 22, 2011, and effective as of the
Closing Date (as hereinafter defined), by and between CAREMORE HEALTH GROUP, Inc. (“Group” or the “Employer”) and LEEBA
LESSIN (the “Employee”). 
  
 WHEREAS, Group and the Employee are parties to an Employment Agreement, dated February 28, 2006 (the “Employment Agreement”); 

 
 WHEREAS, Group and the Employee are parties to a First
Amendment to Employment Agreement and Non-Competition Agreement dated June 8, 2011 (the “First Amendment”) and desire to further amend and restate in full the First Amendment as provided herein; 

 
 WHEREAS, the Employee is selling all of her ownership
interest in Group to WellPoint, Inc., an Indiana corporation (“Purchaser”), in accordance with the terms of that certain Purchase and Sale Agreement, dated as of June 8, 2011, by and among Group, each of the holders of
common stock and options of Group identified on Schedule I thereto, Purchaser, ATH Holdings Company, LLC and CareMore L.P., acting in its capacity as Sellers’ Representative; 

 
 WHEREAS, the “Closing Date” shall
have the meaning specified in the Purchase and Sale Agreement; 
  
 WHEREAS, Purchaser has identified the Employee as key to the continued success of Group and wishes to retain and incentivize the Employee following the Closing Date and the Employee wishes to
continue to remain employed by Group and fulfill her duties and responsibilities in good-faith and to the best of her abilities; 
  

WHEREAS, in connection with its acquisition of the whole of the business of Group, Purchaser desires to protect its interest
in the goodwill of the business and the Employee, in her capacity as an owner of a business entity, agrees that such protections are reasonable and necessary; and 

 
 WHEREAS, Group and the Employee hereby wish to amend
the Employment Agreement and enter into a non-competition agreement to give effect to the foregoing. 
  

NOW, THEREFORE, in consideration of the promises and mutual covenants and undertakings set forth herein, the Employment Agreement
shall be amended as follows: 
  

	1.	The definition of “Board” in Section 1 of the Employment Agreement shall be amended and restated to read as follows: 

 
 ““Board” shall mean the board of directors of
Group or any other Person the Board has appointed or delegated authority.” 
  

	2.	Item (ii) in the definition of “Cause” in Section 1 of the Employment Agreement shall be amended and restated to read as follows:

  
 “(ii) willful disregard of
Employee’s duties or Employee’s intentional failure to act where the taking of such action would be in the ordinary course of the Employee’s duties hereunder; 

  
 1 

 provided that, Employee is first given thirty (30) days prior written notice of such
conduct in order for Employee to cure such alleged conduct during such period of time.” 
  

	3.	A new definition shall be added to Section 1 of the Employment Agreement, after the definition of “Disability” as follows: 

 
 ““Good Reason” shall mean: 

 
 (i) a material reduction during any twenty-four
(24) consecutive month period in Base Salary, or in the Employee’s annual total cash compensation (i.e. Base Salary and target Bonus), but excluding any reduction applicable to management employees generally; 

 
 (ii) a material breach of this Agreement by Group; or

  
 (iii) a change in the Employee’s principal
work location to a location more than 50 miles from the Employee’s prior work location and more than 50 miles from the Employee’s principal residence as of the date of such change in work location. 

 
 Notwithstanding the foregoing provisions of this definition,
Good Reason shall not exist (A) if the Employee has in her sole discretion agreed in writing that such event shall not be Good Reason, or (B) unless, (i) within sixty (60) days of the occurrence of the events claimed to be Good
Reason the Employee notifies the Company in writing of the reasons why he believes that Good Reason exists, (ii) the Company has failed to correct the circumstance that would otherwise be Good Reason within thirty (30) days of receipt of
such notice, and (iii) the Employee terminates her employment within sixty (60) days of such thirty (30) day period (the “Early Resignation Date”).” 

 

	4.	Item (i) in the definition of “Termination Date” in Section 1 of the Employment Agreement shall be amended and restated as follows:

  
 “in the case of termination
by resignation without Good Reason, shall mean the date that is ninety (90) days following the date of the Employee’s written notice to the Employer of her resignation; or in the case of resignation with Good Reason shall mean the Early
Resignation Date; provided, however, that in each case the Employer may accelerate the Termination Date;” 
  

	5.	The second sentence of Section 2 of the Employment Agreement shall be amended and restated to read as follows: 

 
 “The initial term of this Agreement (the
“Initial Term”) shall commence on the Closing Date and end on December 31, 2013; provided, however, that on December 31, 2013 and each December 31 thereafter (each, a “Renewal
Date”), the term of this Agreement shall be extended by one additional year (each, an “Extension Term”, and collectively with the Initial Term, the “Employment Period”)
unless either party gives written notice to the other within ninety (90) days in advance of the next scheduled Renewal Date that it does not wish to extend the Employment Period (such notice, a “Notice of
Nonrenewal”); and provided, further, that the Employment Period may be sooner terminated as provided herein.” 

  
 2 

	6.	The first three sentences of Section 3 of the Employment Agreement shall be amended to reflect the Employee’s new title: 

 
 “During the Employment Period, the Employee shall serve
as President, CareMore Health Plan Division, and shall have the usual and customary duties, responsibilities and authority of such position, and, if elected or appointed thereto, shall serve as an officer and/or member of the board of any
Subsidiary or Affiliate of Group as reasonably requested by the Employer and its Affiliates, in each case, without additional compensation hereunder.” 
  

	7.	Section 4(a) of the Employment Agreement shall be amended to add the following proviso: 

  
 “; provided, that as of the Closing Date, the Employee’s annual base salary shall be increased
prospectively to $350,000.” 
  

	8.	Section 4(b) of the Employment Agreement shall be amended to reflect the following bonus arrangements with respect to fiscal years commencing after the Closing
Date: 

  
 During the Employment
Period, the Employee shall be eligible to participate in Wellpoint’s Annual Incentive Plan (as amended from time to time). The Target Bonus Percentage will be 50% of Base Salary and the Maximum Bonus Percentage will be 100% of Base Salary.
Bonuses will be paid at the same time as similarly situated senior executives of WellPoint, Inc. 
  
 For the avoidance of doubt, any contrary provision in Section 4(b) shall be disregarded. 
  

	9.	Section 4(c) of the Employment Agreement shall be amended and restated as follows: 

  
 “Employee Benefits and Air Travel. During the Employment Period, retirement, health and welfare
benefits will be provided subject to Group’s (and, following a transition period, WellPoint’s) policies and practices and the terms of the applicable benefit plans and arrangements as in effect from time to time. During the Initial Term,
the Employee is eligible to fly first class/business class on business trips. In addition, pursuant to WellPoint’s Directed Executive Compensation program (as amended from time to time), the Employee shall receive an annual allowance of $7,200
which will be paid in equal monthly installments, beginning with the first month after the Closing Date. 
  

	10.	A new Section 4(d) shall be added to the Employment Agreement as follows: 

 
 “Key Employee Retention Plan. During 2012 and
2013, the Employee will be eligible to participate in a special retention bonus plan to be established by WellPoint, Inc., in accordance with the terms of such plan. Cash awards under this plan will be based on the achievement of specified
performance goals, and the Employee’s individual target award level will be 50% of Base Salary.” 
  

	11.	A new Section 4(e) shall be added to the Employment Agreement as follows: 

 
 “Long Term Incentive Program. During the
Employment Period, the Employee shall be eligible to participate in WellPoint’s Incentive Compensation Plan (as amended from time to time) on the same basis as similarly situated senior executives of WellPoint, Inc.” 

 
 For reference purposes only, the ASC718 cost of the 2011
target stock grant for similarly situated senior employees was $285,000. 

  
 3 

	12.	All subsequent sub-sections in Section 4 (including any internal cross-references therein) shall be renumbered accordingly. 

 

	13.	A new Section 5(e) shall be added to the Employment Agreement as follows: 

 
 “Resignation with Good Reason. The Employee may
terminate this Agreement and the Employee’s employment hereunder for Good Reason as of the Early Termination Date (see definition of “Good Reason”).” 

 

	14.	All subsequent sub-sections of Section 5 (including any cross-references therein) shall be renumbered accordingly. 

 

	15.	The introduction to Section 6(c) of the Employment Agreement shall be amended and restated as follows: 

 
 “Termination without Cause, Resignation with Good
Reason, or by Death or Disability. Subject to Section 6(d), in the event of the termination of employment hereunder by reason of (i) Termination without Cause (ii) resignation with Good Reason, or (iii) death or Disability, the
Employee shall be entitled to the following (the “Severance Benefits”):” 
  

	16.	Section 6(c) of the Employment Agreement shall be amended to add the following clause (iv): 

  
 “(iv) in the event the Termination Date occurs during the Initial Term, the Employee shall receive an
additional severance amount equal to the sum of the amounts under clause (i) and clause (ii) above.” 
  

	17.	The first sentence of Section 12 of the Employment Agreement shall be amended as follows: 

  
 “During the Employment Period, and in the event of the termination of the Employee’s employment or
this Agreement for any reason, for a period of one (1) year thereafter, the Employee shall not, directly or indirectly:” 
  

	18.	Section 12(a) of the Employment Agreement shall be amended to add the following phrase before the semi-colon: 

 
 “or hire or attempt to hire any employee of the
Company”; 
  

	19.	Section 12(b) of the Employment Agreement shall be amended to add the following phrase before the semi-colon: 

 
 “or WellPoint, Inc. or their respective directors,
employees, officers and managers”; 
  

	20.	A new Section 13 shall be added to the Employment Agreement as follows: 

 
 “Non-Competition. In consideration of the
acquisition by WellPoint, Inc. of the Employee’s ownership interest in Group and solely in her capacity as an owner of a business entity, the Employee hereby agrees to the following non-competition covenant for the express benefit of WellPoint,
Inc. The Employee understands and acknowledges that this non-competition covenant is of critical importance to WellPoint, Inc. and that WellPoint, Inc. would not have agreed to acquire the Employee’s ownership interest in Group in the absence
of this covenant. The inclusion of this non-competition covenant in this document is for convenience only. Accordingly, this Section 13 shall survive any termination of this Agreement, and shall continue in full force and effect for the
duration of the Restriction Period for the benefit of WellPoint, Inc. 

  
 4 

 During the twenty-four (24) month period of time following the Closing Date (the
“Restriction Period”), the Employee will not, without prior written consent of the Company, directly or indirectly, (a) have an equity interest (including options and convertible instruments) in a Competitor in a Restricted
Territory (excluding for this purpose passive ownership of up to 1% of publicly traded stock) or (b) seek or obtain a Competitive Position in a Restricted Territory and perform a Restricted Activity with a Competitor, as those terms are defined
herein. 
  

	 	(i)	Competitive Position means any employment or performance of services with a Competitor (A) in which the Employee has board level (corporate, advisory or
similar) or executive level duties for such Competitor, or (B) in which the Employee will use any Confidential Information of the Company. 

  

	 	(ii)	Restricted Territory means any geographic area in which the Company does business and in which the Employee had responsibility for, or Confidential Information
about, such business. 

  

	 	(iii)	Restricted Activity means any activity for which the Employee had responsibility for the Company or about which the Employee had Confidential Information.

  

	 	(iv)	Competitor means any entity or individual (other than the Company) engaged in products or services substantially the same or similar to those offered by the
Company.” 

  

	21.	All subsequent sections (including any internal cross-references therein) shall be renumbered accordingly. 

 

	22.	As a result of the addition of new Sections 13 and 14, the proviso in the definition of “Company” in Section 1 shall be expanded to include Sections 13
and 14 as well (i.e., Sections 9, 10, 11, 12, 13 and 14). 

  

	23.	A new Section 14 shall be added to the Employment Agreement as follows: 

 
 “Enforcement. The Employee acknowledges that the
provision of Sections 12 and 13 of this Agreement are reasonable and necessary to protect the continuing interests of the Company, and any violation of Section 12 or 13 will result in irreparable injury to the Company and/or WellPoint, Inc.,
the exact amount of which will be difficult to ascertain, and that the remedies at law for any such violation would not reasonably or adequately compensate the Company and/or WellPoint, Inc. for such a violation. Accordingly, the Employee agrees
that if the Employee violates any of the provisions of Section 12 or 13, in addition to any other remedy which may be available at law or in equity, the Company shall be entitled to specific performance and injunctive relief, without the
necessity of proving actual damages.” 
  

	24.	A new Section 15 shall be added to the Employment Agreement as follows: 

 
 “Cooperation. Upon the receipt of reasonable
notice from Group (including from outside counsel to Group), the Employee agrees that while employed by Group and for two (2) years (or, if longer, for so long as any claim referred to in this Section remains pending) after the termination of
the Employee’s employment for any reason, the Employee will respond and provide information with regard to matters in which the Employee has knowledge as a result of the Employee’s employment with Group, and will provide reasonable
assistance to Group, its 

  
 5 

 
affiliates and their respective representatives in defense of any claims that may be made against Group or its affiliates, and will assist Group and its affiliates in the prosecution of any
claims that may be made by Group or its affiliates, to the extent that such claims may relate to the period of the Employee’s employment with Group (or any predecessor); provided, that with respect to periods after the termination of the
Employee’s employment, Group shall reimburse the Employee for any reasonable out-of-pocket expenses incurred in providing such assistance and if the Employee is required to provide more than ten (10) hours of assistance per week after her
termination of employment then Group shall pay the Employee a reasonable amount of money for her services at a rate agreed to between Group and the Employee; and provided further that after the Employee’s termination of employment with Group
such assistance shall not unreasonably interfere with the Employee’s business or personal obligations. The Employee agrees to promptly inform Group if the Employee becomes aware of any lawsuits involving such claims that may be filed or
threatened against Group or its affiliates. The Employee also agrees to promptly inform Group (to the extent the Employee is legally permitted to do so) if the Employee is asked to assist in any investigation of Group or its affiliates (or their
actions), regardless of whether a lawsuit or other proceeding has then been filed against Group or its affiliates with respect to such investigation, and shall not do so unless legally required.” 

 

	25.	A new Section 16 shall be added to the Employment Agreement as follows: 

 
 “Disclosure and Assignment of Inventions and
Improvements. Without prejudice to any other duties express or implied imposed on the Employee hereunder it shall be part of the Employee’s normal duties at all times to consider in what manner and by what methods or devices the products,
services, processes, equipment or systems of the Company and any customer or vendor of the Company might be improved and promptly to give to the Chief Executive Officer of the Company or his or her designee full details of any improvement,
invention, research, development, discovery, design, code, model, suggestion or innovation (collectively called “Work Product”), which the Employee (alone or with others) may make, discover, create or conceive in the course of the
Employee’s employment. The Employee acknowledges that the Work Product is the property of the Company. To the extent that any of the Work Product is capable of protection by copyright, the Employee acknowledges that it is created within the
scope of the Employee’s employment and is a work made for hire. To the extent that any such material may not be a work made for hire, the Employee hereby assigns to the Company all rights in such material. To the extent that any of the Work
Product is an invention, discovery, process or other potentially patentable subject matter (the “Inventions”), the Employee hereby assigns to the Company all right, title, and interest in and to all Inventions. The Company
acknowledges that the assignment in the preceding sentence does not apply to an Invention that the Employee develops entirely on her own time without using the Company’s equipment, supplies, facilities or trade secret information, except for
those Inventions that either: 
  

	 	(i)	relate at the time of conception or reduction to practice of the Invention to the Company’s business, or actual or demonstrably anticipated research or development
of the Company, or 

  

	 	(ii)	result from any work performed by the Employee for the Company. 

  
 6 

 Execution of the Employment Agreement constitutes the Employee’s acknowledgment of
receipt of written notification of this Section and of notice of the general exception to assignments of Inventions provided under the Uniform Employee Patents Act, in the form adopted by the state having jurisdiction over this Employment Agreement
or provision, or any comparable applicable law.” 
  

	26.	All subsequent sections (including any internal cross-references therein) shall be renumbered accordingly. 

 

	27.	The second and third paragraphs of Section 24(b) of the Employment Agreement shall be amended and restated as follows: 

 

			
	 “with a copy to:
	  	WellPoint, Inc.
		  	120 Monument Circle
		  	Indianapolis, IN 46204
		  	Facsimile: (317) 488 6028
		  	Attention: Chief Human Resources Officer”

  

	28.	General Provisions 

  

	 	(a)	Unless otherwise defined herein, capitalized terms utilized in this Second Amendment shall have the same ascribed to them in the Employment Agreement.

  

	 	(b)	Except as specifically amended by this Second Amendment, the Employment Agreement shall continue in full force and effect. 

 

	 	(c)	The parties may execute this Second Amendment in two or more counterparts. Each counterpart shall be deemed an original instrument as against any party who has signed
it. 

  

	 	(d)	The Employment Agreement, as amended by this Second Amendment, states the entire agreement between the parties with respect to the subject matter hereof and thereof,
including compensation, and supersedes any prior or contemporaneous oral or written proposals, statements, discussions, negotiations, or other agreements (including, but not limited to, the First Amendment). In the event of any inconsistency or
conflict between any term or condition of the Employment Agreement (including any exhibit, schedule or attachment thereto) and this Second Amendment, the terms of this Second Amendment shall govern and be controlling. All references in the
Employment Agreement (including in any exhibits, schedules and other attachments) to “this Agreement,” “herein,” “hereunder” or any similar reference shall be deemed to mean and refer to the Employment Agreement, as
amended by this Second Amendment. 

  
 7 

 IN WITNESS WHEREOF, each of the parties hereto has duly
executed this Second Amendment to Employment Agreement and Non-Competition Agreement as of the date first written above. 
  

			
	CAREMORE HEALTH GROUP, INC.
		
	 By:
	 	

		 	 Name:

		 	 Title:

		
		 	 

		 	 Leeba Lessin

  

ACKNOWLEDGED, ACCEPTED AND AGREED this 22nd day of August 2011 solely with respect to the non-competition
covenant contained herein: 
  

			
	WELLPOINT, INC.
		
	 By:
	 	

		 	 Name: Wayne S. DeVeydt

		 	 Title: Chief Financial Officer and Executive Vice President

 Exhibit 10.14 

 
 Summary of Employment Terms 

Leeba Lessin and WellPoint, Inc. 
 Effective September 20, 2012 
  

	•	 	 Base Annual Salary of $500,000 

 Payment of base salary, as it may be adjusted, guaranteed through December 31, 2014, even if employment terminated without cause prior to that date. 

 

	•	 	 Annual Incentive Program (AIP) target of 70% of base salary 

 Will be eligible for an AIP payment through December 31, 2014, even if employment terminated without cause prior to that date. 

 

	•	 	 Eligible for stock grants under the Long-Term Stock Incentive Program at executive level. Awards granted will continue to vest even if employment
terminated without cause prior to December 31, 2014. 

  

	•	 	 Opportunity to participate in the Executive Agreement Plan, including all severance and other benefits, if elect to do so prior to December 31,
2014.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}]]